All Categories
The GenoMethods taxonomy organizes biotechnology coverage by editorial beat, story type and reader need.
Main sections
AI in Biology
Computational models, scientific agents, biological foundation systems and machine learning applied to living systems This section matters because it gives readers a durable path through a fast field and keeps coverage tied to methods, evidence and practical consequences.
Bioinformatics Methods
Algorithms, reproducible workflows, statistical designs and software practices for biological data This section matters because it gives readers a durable path through a fast field and keeps coverage tied to methods, evidence and practical consequences.
Genomics
Human genomes, population studies, sequencing technologies and variant interpretation This section matters because it gives readers a durable path through a fast field and keeps coverage tied to methods, evidence and practical consequences.
Functional Genomics
Expression dynamics, regulatory networks, pathway analysis and genome-scale perturbation This section matters because it gives readers a durable path through a fast field and keeps coverage tied to methods, evidence and practical consequences.
Drug Discovery
Target discovery, molecule design, translational pipelines and clinical development signals This section matters because it gives readers a durable path through a fast field and keeps coverage tied to methods, evidence and practical consequences.
Gene Editing
CRISPR systems, base editing, prime editing, delivery and therapeutic applications This section matters because it gives readers a durable path through a fast field and keeps coverage tied to methods, evidence and practical consequences.
Cell and Gene Therapy
Engineered cells, viral vectors, manufacturing, clinical outcomes and access questions This section matters because it gives readers a durable path through a fast field and keeps coverage tied to methods, evidence and practical consequences.
Diagnostics
Screening, biomarkers, liquid biopsy, molecular tests and early detection systems This section matters because it gives readers a durable path through a fast field and keeps coverage tied to methods, evidence and practical consequences.
Precision Medicine
Patient stratification, companion diagnostics, real-world evidence and individualized care This section matters because it gives readers a durable path through a fast field and keeps coverage tied to methods, evidence and practical consequences.
Synthetic Biology
Designed organisms, engineered enzymes, biofoundries and programmable biology This section matters because it gives readers a durable path through a fast field and keeps coverage tied to methods, evidence and practical consequences.
Longevity Science
Healthspan, aging mechanisms, biomarkers, geroscience and translational claims This section matters because it gives readers a durable path through a fast field and keeps coverage tied to methods, evidence and practical consequences.
Regenerative Medicine
Organoids, tissue engineering, reprogramming and repair biology This section matters because it gives readers a durable path through a fast field and keeps coverage tied to methods, evidence and practical consequences.
Data and Repositories
Datasets, standards, atlases, ontologies and public knowledge infrastructure This section matters because it gives readers a durable path through a fast field and keeps coverage tied to methods, evidence and practical consequences.
Tools and Platforms
Lab software, sequencing systems, automation, notebooks, models and APIs This section matters because it gives readers a durable path through a fast field and keeps coverage tied to methods, evidence and practical consequences.
Biotech Companies
Profiles, platform analysis, strategy, financing and product ecosystems This section matters because it gives readers a durable path through a fast field and keeps coverage tied to methods, evidence and practical consequences.
Clinical Trials
Study design, endpoints, readouts, safety signals and trial interpretation This section matters because it gives readers a durable path through a fast field and keeps coverage tied to methods, evidence and practical consequences.
Regulation and Policy
FDA, EMA, MHRA, data governance, approvals and public rules This section matters because it gives readers a durable path through a fast field and keeps coverage tied to methods, evidence and practical consequences.
Ethics and Society
Genomic privacy, biosecurity, equity, consent and public trust This section matters because it gives readers a durable path through a fast field and keeps coverage tied to methods, evidence and practical consequences.
Science Communication
Explainers, glossaries, visual guides and public understanding of biotechnology This section matters because it gives readers a durable path through a fast field and keeps coverage tied to methods, evidence and practical consequences.
History and Archives
Historical methods, restored context, timelines and the evolution of bioinformatics This section matters because it gives readers a durable path through a fast field and keeps coverage tied to methods, evidence and practical consequences.
Full category table
| ID | Parent | Name | Description |
|---|---|---|---|
| C01 | AI in Biology | Computational models, scientific agents, biological foundation systems and machine learning applied to living systems | |
| C01-01 | C01 | AI in Biology Daily Brief | Daily Brief coverage for ai in biology, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C01-02 | C01 | AI in Biology Deep Explainer | Deep Explainer coverage for ai in biology, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C01-03 | C01 | AI in Biology Methods Spotlight | Methods Spotlight coverage for ai in biology, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C01-04 | C01 | AI in Biology Company Profile | Company Profile coverage for ai in biology, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C01-05 | C01 | AI in Biology Trial Watch | Trial Watch coverage for ai in biology, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C02 | Bioinformatics Methods | Algorithms, reproducible workflows, statistical designs and software practices for biological data | |
| C02-01 | C02 | Bioinformatics Methods Daily Brief | Daily Brief coverage for bioinformatics methods, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C02-02 | C02 | Bioinformatics Methods Deep Explainer | Deep Explainer coverage for bioinformatics methods, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C02-03 | C02 | Bioinformatics Methods Methods Spotlight | Methods Spotlight coverage for bioinformatics methods, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C02-04 | C02 | Bioinformatics Methods Company Profile | Company Profile coverage for bioinformatics methods, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C02-05 | C02 | Bioinformatics Methods Trial Watch | Trial Watch coverage for bioinformatics methods, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C03 | Genomics | Human genomes, population studies, sequencing technologies and variant interpretation | |
| C03-01 | C03 | Genomics Daily Brief | Daily Brief coverage for genomics, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C03-02 | C03 | Genomics Deep Explainer | Deep Explainer coverage for genomics, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C03-03 | C03 | Genomics Methods Spotlight | Methods Spotlight coverage for genomics, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C03-04 | C03 | Genomics Company Profile | Company Profile coverage for genomics, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C03-05 | C03 | Genomics Trial Watch | Trial Watch coverage for genomics, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C04 | Functional Genomics | Expression dynamics, regulatory networks, pathway analysis and genome-scale perturbation | |
| C04-01 | C04 | Functional Genomics Daily Brief | Daily Brief coverage for functional genomics, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C04-02 | C04 | Functional Genomics Deep Explainer | Deep Explainer coverage for functional genomics, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C04-03 | C04 | Functional Genomics Methods Spotlight | Methods Spotlight coverage for functional genomics, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C04-04 | C04 | Functional Genomics Company Profile | Company Profile coverage for functional genomics, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C04-05 | C04 | Functional Genomics Trial Watch | Trial Watch coverage for functional genomics, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C05 | Drug Discovery | Target discovery, molecule design, translational pipelines and clinical development signals | |
| C05-01 | C05 | Drug Discovery Daily Brief | Daily Brief coverage for drug discovery, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C05-02 | C05 | Drug Discovery Deep Explainer | Deep Explainer coverage for drug discovery, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C05-03 | C05 | Drug Discovery Methods Spotlight | Methods Spotlight coverage for drug discovery, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C05-04 | C05 | Drug Discovery Company Profile | Company Profile coverage for drug discovery, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C05-05 | C05 | Drug Discovery Trial Watch | Trial Watch coverage for drug discovery, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C06 | Gene Editing | CRISPR systems, base editing, prime editing, delivery and therapeutic applications | |
| C06-01 | C06 | Gene Editing Daily Brief | Daily Brief coverage for gene editing, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C06-02 | C06 | Gene Editing Deep Explainer | Deep Explainer coverage for gene editing, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C06-03 | C06 | Gene Editing Methods Spotlight | Methods Spotlight coverage for gene editing, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C06-04 | C06 | Gene Editing Company Profile | Company Profile coverage for gene editing, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C06-05 | C06 | Gene Editing Trial Watch | Trial Watch coverage for gene editing, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C07 | Cell and Gene Therapy | Engineered cells, viral vectors, manufacturing, clinical outcomes and access questions | |
| C07-01 | C07 | Cell and Gene Therapy Daily Brief | Daily Brief coverage for cell and gene therapy, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C07-02 | C07 | Cell and Gene Therapy Deep Explainer | Deep Explainer coverage for cell and gene therapy, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C07-03 | C07 | Cell and Gene Therapy Methods Spotlight | Methods Spotlight coverage for cell and gene therapy, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C07-04 | C07 | Cell and Gene Therapy Company Profile | Company Profile coverage for cell and gene therapy, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C07-05 | C07 | Cell and Gene Therapy Trial Watch | Trial Watch coverage for cell and gene therapy, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C08 | Diagnostics | Screening, biomarkers, liquid biopsy, molecular tests and early detection systems | |
| C08-01 | C08 | Diagnostics Daily Brief | Daily Brief coverage for diagnostics, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C08-02 | C08 | Diagnostics Deep Explainer | Deep Explainer coverage for diagnostics, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C08-03 | C08 | Diagnostics Methods Spotlight | Methods Spotlight coverage for diagnostics, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C08-04 | C08 | Diagnostics Company Profile | Company Profile coverage for diagnostics, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C08-05 | C08 | Diagnostics Trial Watch | Trial Watch coverage for diagnostics, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C09 | Precision Medicine | Patient stratification, companion diagnostics, real-world evidence and individualized care | |
| C09-01 | C09 | Precision Medicine Daily Brief | Daily Brief coverage for precision medicine, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C09-02 | C09 | Precision Medicine Deep Explainer | Deep Explainer coverage for precision medicine, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C09-03 | C09 | Precision Medicine Methods Spotlight | Methods Spotlight coverage for precision medicine, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C09-04 | C09 | Precision Medicine Company Profile | Company Profile coverage for precision medicine, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C09-05 | C09 | Precision Medicine Trial Watch | Trial Watch coverage for precision medicine, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C10 | Synthetic Biology | Designed organisms, engineered enzymes, biofoundries and programmable biology | |
| C10-01 | C10 | Synthetic Biology Daily Brief | Daily Brief coverage for synthetic biology, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C10-02 | C10 | Synthetic Biology Deep Explainer | Deep Explainer coverage for synthetic biology, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C10-03 | C10 | Synthetic Biology Methods Spotlight | Methods Spotlight coverage for synthetic biology, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C10-04 | C10 | Synthetic Biology Company Profile | Company Profile coverage for synthetic biology, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C10-05 | C10 | Synthetic Biology Trial Watch | Trial Watch coverage for synthetic biology, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C11 | Longevity Science | Healthspan, aging mechanisms, biomarkers, geroscience and translational claims | |
| C11-01 | C11 | Longevity Science Daily Brief | Daily Brief coverage for longevity science, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C11-02 | C11 | Longevity Science Deep Explainer | Deep Explainer coverage for longevity science, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C11-03 | C11 | Longevity Science Methods Spotlight | Methods Spotlight coverage for longevity science, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C11-04 | C11 | Longevity Science Company Profile | Company Profile coverage for longevity science, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C11-05 | C11 | Longevity Science Trial Watch | Trial Watch coverage for longevity science, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C12 | Regenerative Medicine | Organoids, tissue engineering, reprogramming and repair biology | |
| C12-01 | C12 | Regenerative Medicine Daily Brief | Daily Brief coverage for regenerative medicine, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C12-02 | C12 | Regenerative Medicine Deep Explainer | Deep Explainer coverage for regenerative medicine, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C12-03 | C12 | Regenerative Medicine Methods Spotlight | Methods Spotlight coverage for regenerative medicine, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C12-04 | C12 | Regenerative Medicine Company Profile | Company Profile coverage for regenerative medicine, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C12-05 | C12 | Regenerative Medicine Trial Watch | Trial Watch coverage for regenerative medicine, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C13 | Data and Repositories | Datasets, standards, atlases, ontologies and public knowledge infrastructure | |
| C13-01 | C13 | Data and Repositories Daily Brief | Daily Brief coverage for data and repositories, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C13-02 | C13 | Data and Repositories Deep Explainer | Deep Explainer coverage for data and repositories, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C13-03 | C13 | Data and Repositories Methods Spotlight | Methods Spotlight coverage for data and repositories, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C13-04 | C13 | Data and Repositories Company Profile | Company Profile coverage for data and repositories, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C13-05 | C13 | Data and Repositories Trial Watch | Trial Watch coverage for data and repositories, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C14 | Tools and Platforms | Lab software, sequencing systems, automation, notebooks, models and APIs | |
| C14-01 | C14 | Tools and Platforms Daily Brief | Daily Brief coverage for tools and platforms, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C14-02 | C14 | Tools and Platforms Deep Explainer | Deep Explainer coverage for tools and platforms, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C14-03 | C14 | Tools and Platforms Methods Spotlight | Methods Spotlight coverage for tools and platforms, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C14-04 | C14 | Tools and Platforms Company Profile | Company Profile coverage for tools and platforms, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C14-05 | C14 | Tools and Platforms Trial Watch | Trial Watch coverage for tools and platforms, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C15 | Biotech Companies | Profiles, platform analysis, strategy, financing and product ecosystems | |
| C15-01 | C15 | Biotech Companies Daily Brief | Daily Brief coverage for biotech companies, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C15-02 | C15 | Biotech Companies Deep Explainer | Deep Explainer coverage for biotech companies, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C15-03 | C15 | Biotech Companies Methods Spotlight | Methods Spotlight coverage for biotech companies, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C15-04 | C15 | Biotech Companies Company Profile | Company Profile coverage for biotech companies, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C15-05 | C15 | Biotech Companies Trial Watch | Trial Watch coverage for biotech companies, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C16 | Clinical Trials | Study design, endpoints, readouts, safety signals and trial interpretation | |
| C16-01 | C16 | Clinical Trials Daily Brief | Daily Brief coverage for clinical trials, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C16-02 | C16 | Clinical Trials Deep Explainer | Deep Explainer coverage for clinical trials, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C16-03 | C16 | Clinical Trials Methods Spotlight | Methods Spotlight coverage for clinical trials, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C16-04 | C16 | Clinical Trials Company Profile | Company Profile coverage for clinical trials, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C16-05 | C16 | Clinical Trials Trial Watch | Trial Watch coverage for clinical trials, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C17 | Regulation and Policy | FDA, EMA, MHRA, data governance, approvals and public rules | |
| C17-01 | C17 | Regulation and Policy Daily Brief | Daily Brief coverage for regulation and policy, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C17-02 | C17 | Regulation and Policy Deep Explainer | Deep Explainer coverage for regulation and policy, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C17-03 | C17 | Regulation and Policy Methods Spotlight | Methods Spotlight coverage for regulation and policy, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C17-04 | C17 | Regulation and Policy Company Profile | Company Profile coverage for regulation and policy, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C17-05 | C17 | Regulation and Policy Trial Watch | Trial Watch coverage for regulation and policy, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C18 | Ethics and Society | Genomic privacy, biosecurity, equity, consent and public trust | |
| C18-01 | C18 | Ethics and Society Daily Brief | Daily Brief coverage for ethics and society, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C18-02 | C18 | Ethics and Society Deep Explainer | Deep Explainer coverage for ethics and society, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C18-03 | C18 | Ethics and Society Methods Spotlight | Methods Spotlight coverage for ethics and society, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C18-04 | C18 | Ethics and Society Company Profile | Company Profile coverage for ethics and society, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C18-05 | C18 | Ethics and Society Trial Watch | Trial Watch coverage for ethics and society, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C19 | Science Communication | Explainers, glossaries, visual guides and public understanding of biotechnology | |
| C19-01 | C19 | Science Communication Daily Brief | Daily Brief coverage for science communication, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C19-02 | C19 | Science Communication Deep Explainer | Deep Explainer coverage for science communication, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C19-03 | C19 | Science Communication Methods Spotlight | Methods Spotlight coverage for science communication, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C19-04 | C19 | Science Communication Company Profile | Company Profile coverage for science communication, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C19-05 | C19 | Science Communication Trial Watch | Trial Watch coverage for science communication, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C20 | History and Archives | Historical methods, restored context, timelines and the evolution of bioinformatics | |
| C20-01 | C20 | History and Archives Daily Brief | Daily Brief coverage for history and archives, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C20-02 | C20 | History and Archives Deep Explainer | Deep Explainer coverage for history and archives, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C20-03 | C20 | History and Archives Methods Spotlight | Methods Spotlight coverage for history and archives, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C20-04 | C20 | History and Archives Company Profile | Company Profile coverage for history and archives, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
| C20-05 | C20 | History and Archives Trial Watch | Trial Watch coverage for history and archives, built around clear evidence, primary sources and practical context for readers who want more than a headline. |
Companies, products and methods
The second entity layer is a 300-item index of organizations, products, platforms, databases, software tools, therapies and historical methods. It is maintained on the companies and products page.